A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
Our Standards: The Thomson Reuters Trust Principles.
AiRE is designed to identify automated actors before funds move, while the evidence disclosed centers…
The restaurant-software company is pairing commercial leadership with global talent oversight, but disclosed no financial…
Dubai South tops of off-plan sales rankings for eighth month in a row Dubai, UAE,…
The banking software provider says its NVIDIA-powered platform can run across private cloud, managed cloud…
As multi-billion-dollar LNG projects advance toward FID and commissioning, Standard Bank and the Mozambique Oil…
Wes Shattler will lead two consulting offerings aimed at helping payments businesses organize compliance governance…